Literature DB >> 8941051

Procreation after death or mental incompetence: medical advance or technology gone awry?

D A Ohl1, J Park, C Cohen, K Goodman, A C Menge.   

Abstract

OBJECTIVE: To review our experience with semen retrieval in men who are incompetent or dead and to formulate general medical, legal, and ethical guidelines for practitioners.
DESIGN: Case series and literature review.
SETTING: Academic. PATIENT(S): Seven incompetent or neurologically dead individuals in whom sperm retrieval was requested. INTERVENTION(S): Electroejaculation. RESULT(S): Seminal emission was induced in the two men who underwent electroejaculation. Sperm suitable for cryopreservation was obtained in one of these men. Review of the legal and ethical implications of such procedures led to development of general guidelines for determining whether gamete retrieval should be performed when requested. Issues of procreational autonomy, consideration of the decedent's wishes, and assurance of the well-being of any new life created were considered most strongly in the formation of these guidelines. CONCLUSION(S): Although the retrieval of sperm from deceased or incompetent individuals may be achieved readily, it is incumbent upon the practitioner to consider the legal and moral implications of these procedures before proceeding.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  1996        PMID: 8941051     DOI: 10.1016/s0015-0282(16)58680-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

Review 1.  Perimortem and postmortem sperm acquisition: review of clinical data.

Authors:  Stav Oved Ovics; Shira Baram; Simon Nothman; Amir Weiss; Ronit Beck-Fruchter
Journal:  J Assist Reprod Genet       Date:  2022-02-21       Impact factor: 3.357

Review 2.  [Brain death criterion and organ donation: current neuroscientific perspective].

Authors:  Uwe Walter
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-11-12       Impact factor: 1.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.